AbbVie (ABBV) vs the profit jump: shares rise 1.41%
AbbVie (ABBV) shares rose 1.41% to $294.89 after adjusted EPS of $3.82 more than doubled, shaped by a much smaller acquired-research charge than a year earlier.
Single names and indices — earnings, positioning and the bull and bear cases priced side by side.
AbbVie (ABBV) shares rose 1.41% to $294.89 after adjusted EPS of $3.82 more than doubled, shaped by a much smaller acquired-research charge than a year earlier.
Goldman Sachs versus Morgan Stanley, from the quarterly supplements: trading, investment-banking fees, net interest, compensation and book value, line by line.